āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.
āshibio has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in June 2024.
āshibio's investors include MPM Capital, Agent Capital, Mirae Asset Venture Investment, YK Bioventures.
āshibio is headquartered in Brisbane, United States.
āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.
āshibio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"āshibio — Funding & Investors." VCBacked, June 20, 2024, https://www.vcbacked.co/company/shibio. Accessed September 30, 2026.
VCBacked. (2024). āshibio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/shibio
{{cite web |title=āshibio — Funding & Investors |url=https://www.vcbacked.co/company/shibio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated